The trial failure is a blow to hopes that Alzheimer's could open a major new market for GLP-1 medicines such as semaglutide, as Novo faces rising competition to its blockbuster drugs in its core treatment areas of obesity and diabetes
Systemic glutathione depletion, combined with elevated ROS, damages the endothelial lining of the blood vessels
This combination may interact with chemotherapy medicines (like doxorubicin and cisplatin), aluminum-containing antacids (like maalox), estrogen-containing medications (like estradiol), protease inhibitors (like indinavir), statins (like atorvastatin) and anticoagulants (like warfarin)
As an incretin hormone, GLP-1 helps regulate normal metabolic function by supporting glucose-dependent insulin secretion, moderating glucagon release, slowing gastric emptying, promoting satiety, and helping maintain healthy blood sugar levels already in a normal range and energy balance